We are live on ! Find out more
IDXX icon

Idexx Laboratories

671.64 USD
+120.43
21.85%
At close Updated Nov 2, 4:00 PM EST
Pre-market
After hours
667.33
-4.31
0.64%
1 day
21.85%
5 days
19.25%
1 month
29.56%
3 months
18.28%
6 months
19.27%
Year to date
0.25%
1 year
-7.1%
5 years
7.06%
10 years
536.99%
 

About: Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Employees: 11,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 58%
Neutral 38%
Negative 4%
Positive
24/7 Wall Street
18 hours ago
IDEXX Soars 20.2% on Earnings Beat: What It Means for Your S&P 500 Index Fund
Retirement savers who never chose IDEXX Laboratories (NASDAQ:IDXX | IDXX Price Prediction) got a lift from it anyway on Monday. The veterinary diagnostics company was up 20.2% in the regular session as of 1:54 PM ET, trading at $662.
IDEXX Soars 20.2% on Earnings Beat: What It Means for Your S&P 500 Index Fund
Neutral
Seeking Alpha
20 hours ago
IDEXX Laboratories, Inc. (IDXX) Q3 2026 Earnings Call Transcript
IDEXX Laboratories, Inc. (IDXX) Q3 2026 Earnings Call Transcript
IDEXX Laboratories, Inc. (IDXX) Q3 2026 Earnings Call Transcript
Positive
Benzinga
21 hours ago
Aging Pets, Higher Testing Frequency Propel IDEXX Past Wall Street Estimates Despite Slower Clinic Traffic
IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock rose Monday after the company reported better-than-expected third-quarter results and raised 2026 guidance, driven by expansion of diagnostic utilization, growth in global instrument and customer base.
Aging Pets, Higher Testing Frequency Propel IDEXX Past Wall Street Estimates Despite Slower Clinic Traffic
Positive
Reuters
21 hours ago
IDEXX raises forecast, betting diagnostics can offset weak vet visits
IDEXX Laboratories beat quarterly estimates and raised its annual profit and revenue forecast on Monday, betting ​that rising diagnostic use per visit and new ‌product launches will sustain growth through softer veterinary clinic traffic.
IDEXX raises forecast, betting diagnostics can offset weak vet visits
Neutral
The Motley Fool
21 hours ago
IDEXX Sales Rise 10% as Margin Outlook Slips: Rapid Earnings Reaction
IDEXX grew third-quarter revenue 10% to about $1.21 billion, led by an 11% gain in recurring diagnostics sales to vets. The higher 2026 profit forecast doesn't come from testing demand.
IDEXX Sales Rise 10% as Margin Outlook Slips: Rapid Earnings Reaction
Neutral
MarketBeat
21 hours ago
IDEXX Laboratories Q3 Earnings Call Highlights
IDEXX Laboratories NASDAQ: IDXX reported third-quarter 2026 results marked by organic revenue growth, higher diagnostic utilization and expanded placement of its premium instruments, while raising its full-year revenue and earnings outlook.
IDEXX Laboratories Q3 Earnings Call Highlights
Neutral
Zacks Investment Research
22 hours ago
Idexx (IDXX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Idexx (IDXX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Positive
Zacks Investment Research
22 hours ago
IDXX Q3 Earnings & Revenues Surpass Estimates, Stock Up in Pre-Market
IDEXX Laboratories beats Q3 2026 earnings and revenue estimates as diagnostic demand boosts growth and margins expand, prompting higher 2026 revenue and earnings guidance.
IDXX Q3 Earnings & Revenues Surpass Estimates, Stock Up in Pre-Market
Neutral
Benzinga
23 hours ago
IDEXX Laboratories, Perion Network, TAT Technologies And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones gaining around 500 points on Monday.
IDEXX Laboratories, Perion Network, TAT Technologies And Other Big Stocks Moving Higher On Monday
Positive
Investors Business Daily
23 hours ago
Idexx Labs Barks Up A Third-Quarter Beat; Can It Fetch This Next Bullish Move?
Idexx Laboratories outperformed a shaky macro on Monday, beating third-quarter forecasts. Idexx stock surged.
Idexx Labs Barks Up A Third-Quarter Beat; Can It Fetch This Next Bullish Move?
Price charts implemented using Lightweight Charts™